Tirzepatide(Tirzepatide - Injectable)
Dual-Action Weight Loss Power
Dual-action GLP-1 and GIP receptor agonist for weight management. Helps reduce appetite, support metabolic function, and enhance insulin response. Compounded by FDA-registered 503A pharmacies. Individual results vary.
PREMIUM HEALTH
Choose Your Wellness Journey
Select the plan that fits your lifestyle. All plans include our premium formulation and access to our wellness community.
As low as...
$249.00
per month
or $8.30 per day
Select Dosing
Select Interval
Choose an Option
Free Shipping
No Hidden Fees
No Monthly Membership
Financing available through Cherry
Check your eligibility in minutes, no commitment. See payment plans
To complete an order with financing, call 1-888-217-8206 our support team can help you navigate our financing payment option.
Scan to apply
Already a patient? Log in to your Patient Portal to manage your prescriptions.
Available in all 50 states
Best Results Timeline
Optimal weight management results are typically seen within 3-6 months of consistent treatment. While some patients notice changes in the first few weeks, the most significant and sustainable results come with continued use and lifestyle modifications. Individual results vary.
Dual-action weight management
- Activates both GLP-1 and GIP receptors
- Enhanced appetite suppression
- Convenient injectable form
- Compounded tirzepatide
- Compounded by FDA-registered 503A pharmacies
Important Disclosure: Tirzepatide is a compounded medication prepared by FDA-registered 503A compounding pharmacies. Compounded medications are not FDA-approved and may differ in effectiveness, side effects, and risk profile compared to FDA-approved brand-name medications. Not recommended for those with personal/family history of medullary thyroid cancer. Only a healthcare provider can determine if a compounded medication is appropriate for your care. Learn more about our pharmacy partners.